Evaluation of Cell-Penetrating Peptides as Mucosal Immune Enhancers for Nasal Vaccination
- 13 October 2021
- journal article
- research article
- Published by Springer Nature in International Journal of Peptide Research and Therapeutics
- Vol. 27 (4) , 2873-2882
Abstract
Cell-penetrating peptides (CPPs) have been evaluated as enhancers in drug delivery, their addition in medical formulations favors drug absorption allowing obtaining the pharmacological effect with lower doses. In vaccine formulations their inclusion has been also explored with interesting results. Currently mucosal vaccination constitutes a promising alternative with the main advantage of inducing both systemic and mucosal immune responses, which are crucial for control tumors and infections at mucosal tissues. In the present work the nasal immune-enhancing effect of four CPPs was evaluated in Balb/c mice. Animals were intranasally immunized with CPP and the recombinant hepatitis B surface protein (HBsAg) as model antigen. The antibody response in sera and mucosal tissue was measured by ELISA. The IFN-γ secretion response at spleen was also evaluated by ELISPOT and ELISA. Among the CPPs studied one novel peptide stand out by its ability to potentiate the humoral and cellular immune response against the co-administered antigen. Considering that the use of mucosal routes is a promising strategy in vaccination, which are gaining special relevance nowadays in the development of novel candidates against SARS-CoV-2 and other potential emerging respiratory virus, the searching and development of safe mucosal adjuvants constitute a current need. Graphic AbstractKeywords
All Related Versions
Funding Information
- The science and technology innovation Program of Hunan Province (2020RC5035)
- Hunan Provincial Innovative Construction Program (2020WK2031)
This publication has 51 references indexed in Scilit:
- Mechanisms of Cellular Uptake of Cell-Penetrating PeptidesJournal of Biophysics, 2011
- Topical immunization strategiesMucosal Immunology, 2010
- The Effect of the Parenteral Route of Administration on the Immune Response to Simultaneous Nasal and Parenteral Immunizations Using a New HBV Therapeutic Vaccine CandidateViral Immunology, 2010
- Cell-penetrating peptides: Application in vaccine deliveryBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2010
- Elucidating cell-penetrating peptide mechanisms of action for membrane interaction, cellular uptake, and translocation utilizing the hydrophobic counter-anion pyrenebutyrateBiochimica et Biophysica Acta (BBA) - Biomembranes, 2009
- Twenty years of cell‐penetrating peptides: from molecular mechanisms to therapeuticsBritish Journal of Pharmacology, 2009
- A New Potent Secondary Amphipathic Cell–penetrating Peptide for siRNA Delivery Into Mammalian CellsMolecular Therapy, 2009
- Influence of Aluminum-Based Adjuvant on the Immune Response to Multiantigenic FormulationViral Immunology, 2006
- A non-covalent peptide-based strategy for protein and peptide nucleic acid transductionBiochimica et Biophysica Acta (BBA) - Biomembranes, 2006
- Uptake of analogs of penetratin, Tat(48–60) and oligoarginine in live cellsBiochemical and Biophysical Research Communications, 2003